Open AccessUses and Abuses of Tumor Markers in the Diagnosis, Monitoring, and Treatment of Primary and Metastatic Breast Cancer
Author(s) -
Henry N. Lynn,
Hayes Daniel F.
Publication year - 2006
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.11-6-541
Subject(s) - medicine , breast cancer , metastatic breast cancer , oncology , estrogen receptor , cancer
L earning O bjectives After completing this course, the reader will be able to: Identify the difference between prognostic and predictive factors. Describe the evaluation of tumor markers, including their utility, magnitude, and reliability. Discuss issues surrounding tumor markers currently in routine use in breast cancer, including estrogen receptor, Her‐2/neu, and Oncotype DX™.Access and take the CME test online and receive 1 AMA PRA category 1 credit at CME.TheOncologist.com